Transthyretin (TTR) amyloid cardiomyopathy (ATTR‐CM) is an underdiagnosed and progressive disease caused by the deposition of variant or wild‐type TTR amyloid in the myocardium, leading to heart failure (HF).1, 2, 3. This evidence concerns the gene TTR and heart failure.